HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Development of heparanase inhibitors for anti-cancer therapy.

Abstract
Heparanase is an endo-beta-D-glucuronidase that degrades heparan sulfate glycosaminoglycan side chains of the proteoglycans in extracellular matrix and basement membrane. Heparanase enzymatic activity is important in the promotion of tumor angiogenesis, primary tumor growth, invasion, and metastasis. Expression of heparanase in many tumor types conversely correlates with prognosis. Much progress has been made in studying the regulation of heparanase expression, processing and activation. The interaction between heparanase and its substrate heparan sulfate has been well characterized. The fact that heparanase was identified as the single predominant heparan sulfate-degrading enzyme in human cancer sparked considerable interest in developing heparanase inhibitors for potential therapeutic applications. Recent progress in drug development led to several classes of heparanase inhibitors, including chemically modified natural products, small molecule inhibitors, and antibodies. Some of these inhibitors have demonstrated potent activities to inhibit tumor angiogenesis, tumor progress, or tumor metastasis. A leading compound, PI-88, is currently being evaluated in clinical phase II trials in patients with melanoma, liver, or lung cancers. This review summarizes the recent progress in heparanase biochemical research and the development of heparanase antagonists as novel anti-cancer therapeutics.
AuthorsHua-Quan Miao, Hu Liu, Elizabeth Navarro, Paul Kussie, Zhenping Zhu
JournalCurrent medicinal chemistry (Curr Med Chem) Vol. 13 Issue 18 Pg. 2101-11 ( 2006) ISSN: 0929-8673 [Print] United Arab Emirates
PMID16918340 (Publication Type: Journal Article, Review)
Chemical References
  • Biomarkers
  • Enzyme Inhibitors
  • Sulfates
  • heparanase
  • Glucuronidase
  • Nitrogen
  • Oxygen
Topics
  • Biomarkers (analysis)
  • Drug Design
  • Enzyme Inhibitors (chemistry, pharmacology)
  • Glucuronidase (analysis, antagonists & inhibitors, physiology)
  • Humans
  • Neoplasm Metastasis
  • Neoplasms (drug therapy, pathology)
  • Neovascularization, Pathologic
  • Nitrogen (chemistry)
  • Oxygen (chemistry)
  • Sulfates (chemistry)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: